The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Interleukin-3 amplifies acute inflammation and is a potential therapeutic target in sepsis
Open accessAbstract
A new therapeutic target for sepsis: Infections can sometimes unleash powerful immune responses that careen out of control, leading to sepsis, organ failure, and death. Although antibiotics can help to quash the infection, sepsis patients also need therapies that will rein in the immune response. Weber et al. now identify one potential target, the secreted protein interleukin-3 (IL-3) (see the Perspective by Hotchkiss). In sepsis patients, higher serum concentrations of IL-3 were correlated with higher rates of mortality. In septic mice, IL-3 caused the immune system to produce large amounts of cells called monocytes and neutrophils, which secrete highly inflammatory proteins. Blocking IL-3 protected mice from sepsis-induced death. Science , this issue p. 1260 ; see also p. 1201
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chen, Y., Wang, L., Kang, Q., Zhang, X., Yu, G., Wan, X., Wang, J., & Zhu, K. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000477308 · Cited by 10,679
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J.-L., & Ramsay, G. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050454.01978.3b · Cited by 5,995
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
Severe Sepsis and Septic Shock
Angus, D. C., & van der Poll, T. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1208623 · Cited by 3,961
Genomic responses in mouse models poorly mimic human inflammatory diseases
Seok, J., Warren, H. S., Cuenca, A. G., Mindrinos, M. N., Baker, H. V., Xu, W., Richards, D. R., McDonald-Smith, G. P., Gao, H., Hennessy, L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222878110 · Cited by 3,005
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
Hotchkiss, R. S., Monneret, G., & Payen, D. (2013) · Nature Reviews Immunology · doi:10.1038/nri3552 · Cited by 2,772
Immunodesign of experimental sepsis by cecal ligation and puncture
Rittirsch, D., Huber-Lang, M. S., Flierl, M. A., & Ward, P. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.214 · Cited by 2,209
Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure
Boomer, J. S., To, K., Chang, K. C., Takasu, O., Osborne, D. F., Walton, A. H., Bricker, T. L., Jarman, S. D., Kreisel, D., Krupnick, A. S., et al. (2011) · JAMA · doi:10.1001/jama.2011.1829 · Cited by 1,781
Annane, D., Bellissant, E., & Cavaillon, J.-M. (2005) · The Lancet · doi:10.1016/s0140-6736(04)17667-8 · Cited by 1,213
Biology of Hematopoietic Stem Cells and Progenitors: Implications for Clinical Application
Kondo, M., Wagers, A. J., Manz, M. G., Prohaska, S. S., Scherer, D. C., Beilhack, G. F., Shizuru, J. A., & Weissman, I. L. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141007 · Cited by 997
Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis
Williams, G. T., Smith, C. A., Spooncer, E., Dexter, T. M., & Taylor, D. R. (1990) · Nature · doi:10.1038/343076a0 · Cited by 895
Opal, S. M., Fisher, C. J., Dhainaut, J.-F. A., Vincent, J.-L., Brase, R., Lowry, S. F., Sadoff, J. C., Slotman, G. J., Levy, H., Balk, R. A., et al. (1997) · Critical Care Medicine · doi:10.1097/00003246-199707000-00010 · Cited by 865
Yang, Y.-C., Ciarletta, A. B., Temple, P. A., Chung, M. P., Kovacic, S., Witek-Giannotti, J. S., Leary, A. C., Kriz, R., Donahue, R. E., Wong, G. G., et al. (1986) · Cell · doi:10.1016/0092-8674(86)90360-0 · Cited by 766
Sepsis: Current Dogma and New Perspectives
Deutschman, C. S., & Tracey, K. J. (2014) · Immunity · doi:10.1016/j.immuni.2014.04.001 · Cited by 677
The sepsis seesaw: tilting toward immunosuppression
Hotchkiss, R. S., Coopersmith, C. M., McDunn, J. E., & Ferguson, T. A. (2009) · Nature Medicine · doi:10.1038/nm0509-496 · Cited by 574
The inflammatory response in sepsis
Bosmann, M., & Ward, P. A. (2013) · Trends in Immunology · doi:10.1016/j.it.2012.09.004 · Cited by 558
Genomic responses in mouse models greatly mimic human inflammatory diseases
Takao, K., & Miyakawa, T. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1401965111 · Cited by 500
Groopman, J. E., Molina, J.-M., & Scadden, D. T. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911233212106 · Cited by 448
Innate Response Activator B Cells Protect Against Microbial Sepsis
Rauch, P. J., Chudnovskiy, A., Robbins, C. S., Weber, G. F., Etzrodt, M., Hilgendorf, I., Tiglao, E., Figueiredo, J.-L., Iwamoto, Y., Theurl, I., et al. (2012) · Science · doi:10.1126/science.1215173 · Cited by 409
Self-citationRegulation of B1 cell migration by signals through Toll-like receptors
Ha, S.-A., Tsuji, M., Suzuki, K., Meek, B., Yasuda, N., Kaisho, T., & Fagarasan, S. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061041 · Cited by 290
Pleural innate response activator B cells protect against pneumonia via a GM-CSF-IgM axis
Weber, G. F., Chousterman, B. G., Hilgendorf, I., Robbins, C. S., Theurl, I., Gerhardt, L. M. S., Iwamoto, Y., Quách, T. D., Ali, M., Chen, J. W., et al. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20131471 · Cited by 157
Self-citationHilgendorf, I., Theurl, I., Gerhardt, L. M. S., Robbins, C. S., Weber, G. F., Gonen, A., Iwamoto, Y., Degousée, N., Holderried, T. A. W., Winter, C., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.006381 · Cited by 147
Self-citationCoopersmith, C. M., Wunsch, H., Fink, M. P., Linde‐Zwirble, W. T., Olsen, K. M., Sommers, M. S., Anand, K. J. S., Tchorz, K. M., Angus, D. C., & Deutschman, C. S. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e31823c8d03 · Cited by 142
Ohmori, K., Luo, Y., Jia, Y., Nishida, J., Wang, Z., Bunting, K. D., Wang, D., & Huang, H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802870 · Cited by 134
New approaches to the study of sepsis
Ward, P. A. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201201375 · Cited by 110
Colvin, G. A., Lambert, J.-F., Abedi, M., et al. (2004) · Leukemia · doi:10.1038/sj.leu.2403268 · Cited by 100
Ward, P. A. (2011) · JAMA · doi:10.1001/jama.2011.1831 · Cited by 76
Basophil modulation by cytokine instruction
Voehringer, D. (2012) · European Journal of Immunology · doi:10.1002/eji.201142318 · Cited by 64
Human thymic epithelial cells produce interleukin-3
Dalloul, A. H., Arock, M., Fourcade, C., Hatzfeld, A., Bertho, J., Debré, P., & Mossalayi, M. D. (1991) · Blood · doi:10.1182/blood.v77.1.69.69 · Cited by 55
Pharmacoeconomic Implications of New Therapies in Sepsis
Wood, K. A., & Angus, D. C. (2004) · PharmacoEconomics · doi:10.2165/00019053-200422140-00001 · Cited by 54
Methylglyoxal as a new biomarker in patients with septic shock: an observational clinical study
Brenner, T., Fleming, T. H., Uhle, F., Silaff, S., Schmitt, F. C. F., Salgado, E., Ulrich, A. B., Zimmermann, S., Bruckner, T. M., Martin, E., et al. (2014) · Critical Care · doi:10.1186/s13054-014-0683-x · Cited by 48
Self-citationOrigin, maturation and recruitment of mast cell precursors
Jamur, M. C. (2011) · Frontiers in Bioscience-Scholar · doi:10.2741/231 · Cited by 42
Rönnberg, E., Johnzon, C., Calounova, G., García‐Faroldi, G., Grujić, M., Hartmann, K., Roers, A., Guss, B., Lundequist, A., & Pejler, G. (2014) · Immunology · doi:10.1111/imm.12297 · Cited by 28
Cited by
The immunopathology of sepsis and potential therapeutic targets
van der Poll, T., van de Veerdonk, F. L., Scicluna, B. P., & Netea, M. G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.36 · Cited by 1,957
Cytokine storm and sepsis disease pathogenesis
Chousterman, B. G., Swirski, F. K., & Weber, G. F. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0639-8 · Cited by 1,330
Self-citationAdvances in the understanding and treatment of sepsis-induced immunosuppression
Venet, F., & Monneret, G. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.165 · Cited by 981
The immune system’s role in sepsis progression, resolution, and long-term outcome
Delano, M. J., & Ward, P. A. (2016) · Immunological Reviews · doi:10.1111/imr.12499 · Cited by 880
Evrard, M., Kwok, I. W. H., Chong, S. Z., Teng, K. W. W., Becht, E., Chen, J., Sieow, J. L., Penny, H. L., Ching, G. C., Devi, S., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.02.002 · Cited by 705
Metadata
- Authors
- Weber, G. F., Chousterman, B. G., He, S., Fenn, A. M., Nairz, M., Anzai, A., Brenner, T., Uhle, F., Iwamoto, Y., Robbins, C. S., Noiret, L., Maier, S. L., Zönnchen, T., Rahbari, N. N., Schölch, S., Klotzsche-von Ameln, A., Chavakis, T., Weitz, J., Hofer, S., Weigand, M. A., Nahrendorf, M., Weissleder, R., & Swirski, F. K.
- Venue
- Science
- Published
- 2015-03-13
- Volume
- 347
- Issue
- 6227
- Pages
- 1260-1265
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2086143858
- Cited by
- 350
- References
- 33
- FWCI
- 23.16
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.